6-170561958-ACAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG-ACAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP3BP6_ModerateBS2
The NM_003194.5(TBP):c.276_281dup(p.Gln94_Gln95dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00471 in 1,404,802 control chromosomes in the GnomAD database, including 21 homozygotes. Variant has been reported in ClinVar as Likely benign (★). Synonymous variant affecting the same amino acid position (i.e. Q74Q) has been classified as Likely benign.
Frequency
Genomes: 𝑓 0.0042 ( 2 hom., cov: 24)
Exomes 𝑓: 0.0048 ( 19 hom. )
Consequence
TBP
NM_003194.5 inframe_insertion
NM_003194.5 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.290
Genes affected
TBP (HGNC:11588): (TATA-box binding protein) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes TBP, the TATA-binding protein. A distinctive feature of TBP is a long string of glutamines in the N-terminus. This region of the protein modulates the DNA binding activity of the C terminus, and modulation of DNA binding affects the rate of transcription complex formation and initiation of transcription. The number of CAG repeats encoding the polyglutamine tract is usually 25-42, and expansion of the number of repeats to 45-66 increases the length of the polyglutamine string and is associated with spinocerebellar ataxia 17, a neurodegenerative disorder classified as a polyglutamine disease. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP3
Nonframeshift variant in repetitive region in NM_003194.5
BP6
Variant 6-170561958-A-ACAGCAG is Benign according to our data. Variant chr6-170561958-A-ACAGCAG is described in ClinVar as [Likely_benign]. Clinvar id is 445790.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAd4 at 2 AD,AR,Digenic gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBP | NM_003194.5 | c.276_281dup | p.Gln94_Gln95dup | inframe_insertion | 3/8 | ENST00000392092.7 | NP_003185.1 | |
TBP | NM_001172085.2 | c.216_221dup | p.Gln74_Gln75dup | inframe_insertion | 2/7 | NP_001165556.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBP | ENST00000392092.7 | c.276_281dup | p.Gln94_Gln95dup | inframe_insertion | 3/8 | 1 | NM_003194.5 | ENSP00000375942 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00419 AC: 600AN: 143368Hom.: 2 Cov.: 24
GnomAD3 genomes
AF:
AC:
600
AN:
143368
Hom.:
Cov.:
24
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00435 AC: 651AN: 149640Hom.: 1 AF XY: 0.00440 AC XY: 359AN XY: 81604
GnomAD3 exomes
AF:
AC:
651
AN:
149640
Hom.:
AF XY:
AC XY:
359
AN XY:
81604
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00476 AC: 6009AN: 1261328Hom.: 19 Cov.: 0 AF XY: 0.00496 AC XY: 3129AN XY: 630480
GnomAD4 exome
AF:
AC:
6009
AN:
1261328
Hom.:
Cov.:
0
AF XY:
AC XY:
3129
AN XY:
630480
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00419 AC: 601AN: 143474Hom.: 2 Cov.: 24 AF XY: 0.00387 AC XY: 271AN XY: 70062
GnomAD4 genome
AF:
AC:
601
AN:
143474
Hom.:
Cov.:
24
AF XY:
AC XY:
271
AN XY:
70062
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jun 05, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at